Patents by Inventor Ningning SONG

Ningning SONG has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • DISPLAY PANEL AND DISPLAY DEVICE
    Publication number: 20240130174
    Abstract: The present invention discloses a display panel and a display device. The display panel includes a gate driver circuit and a plurality of driving wires. By disposing gate driver circuits with different distribution density in non-bending frame regions and adjusting corresponding driving wires wired from an output end of the gate driver circuit to a bending displaying region, normal driving of the bending displaying region can be achieved and simultaneously damages to the gate driver circuit during folding can be mitigated or obviated.
    Type: Application
    Filed: February 25, 2021
    Publication date: April 18, 2024
    Inventors: Ningning ZHOU, Yanan WANG, Zengjian JIN, Rui JU, Jihui LI, Qiaoya ZHANG, Zhenbo SONG, Tengfei GE
  • Anti-human LAG-3 monoclonal antibody and use thereof
    Patent number: 11685778
    Abstract: Disclosed in the present invention are an antibody targeting LAG-3, a preparation method therefor and the use thereof. In particular, disclosed in the present invention is a novel monoclonal antibody targeting LAG-3. Also disclosed in the present invention is a method for the preparation of the monoclonal antibody. The monoclonal antibody of the present invention is capable of binding LAG-3 antigens with high specificity, and has very high affinity and significant activities such as anti-tumor activity.
    Type: Grant
    Filed: April 2, 2019
    Date of Patent: June 27, 2023
    Assignee: JIANGSU HUAIYU PHARMACEUTICAL CO., LTD.
    Inventors: Ningning Song, Qing Duan, Xiaohui Shao, Peng Wang, Xiaojiao Bian, Qian Wang, Peipei Wei, Yajun Huang, Jian Wu, Meiling Wang, Yuandong Wang, Lina Xu, Tatchi Teddy Yang, Lile Liu
  • ANTI-HUMAN TIM-3 MONOCLONAL ANTIBODY AND APPLICATION THEREOF
    Publication number: 20220033501
    Abstract: Provided are a high-affinity full human monoclonal antibody highly specifically targeting to TIM-3 and a preparation method therefor. The monoclonal antibody has a remarkable antitumor activity, and can be used for preparing a related diagnostic reagent or a pharmaceutical composition preventing or treating diseases related to TIM-3 dysfunction.
    Type: Application
    Filed: December 2, 2019
    Publication date: February 3, 2022
    Inventors: Ningning SONG, Qing DUAN, Lile LIU, Tatchi Teddy YANG, Lina XU, Hu LIU, Peipei WEI, Qian WANG, Yuangdong WANG, Xiaohui SHAO, Shaoping HU, Yu ZHANG, Jian WU, Meilling WANG, Dongxu WANG, Chaohui DAI, Mengying WANG
  • ANTIBODY TARGETING CTLA-4 , PREPARATION METHOD THEREFOR AND USE THEREOF
    Publication number: 20210324080
    Abstract: Disclosed by the present invention are an antibody targeting CTLA-4, a preparation method therefor and a use thereof. In particular, disclosed by the present invention is a novel fully human monoclonal antibody that targets CTLA-4. Further disclosed by the present invention is a method for preparing the monoclonal antibody. The monoclonal antibody of the present invention is capable of binding a CTLA-4 antigen with high specificity, has a high affinity, remarkable anti-tumor activity, and so on.
    Type: Application
    Filed: March 13, 2019
    Publication date: October 21, 2021
    Inventors: Lina XU, Lile LIU, Tatchi Teddy YANG, Yuxing WEI, Xiaohui SHAO, Qian WANG, Jie ZHANG, Meiling WANG, Yu ZHANG, Qing DUAN, Ningning SONG
  • ANTI-HUMAN LAG-3 MONOCLONAL ANTIBODY AND USE THEREOF
    Publication number: 20210155689
    Abstract: Disclosed in the present invention are an antibody targeting LAG-3, a preparation method therefor and the use thereof. In particular, disclosed in the present invention is a novel monoclonal antibody targeting LAG-3. Also disclosed in the present invention is a method for the preparation of the monoclonal antibody. The monoclonal antibody of the present invention is capable of binding LAG-3 antigens with high specificity, and has very high affinity and significant activities such as anti-tumor activity.
    Type: Application
    Filed: April 2, 2019
    Publication date: May 27, 2021
    Applicants: SHANGHAI PHARMAEXPLORER CO., LTD., PHARMAEXPLORER LIMITED
    Inventors: Ningning SONG, Qing DUAN, Xiaohui SHAO, Peng WANG, Xiaojiao BIAN, Qian WANG, Peipei WEI, Yajun HUANG, Jian WU, Meiling WANG, Yuandong WANG, Lina XU, Tatchi Teddy YANG, Lile LIU